Navigator Medicines
NJ - Scotch PlainsBiotechnology
Focus: Navigator Medicines is a pre-revenue biotechnology company focused on bispecific antibody therapeutics for immunology and dermatology indications. The company is early-stage with a single clinical program (NAV-240) in Phase 1/2 development.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Open Jobs
0
About Navigator Medicines
AI assessmentNot HiringNo open roles listed right now. Follow Navigator Medicines to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NAV-240
Healthy VolunteersClinical Trials (1)
NCT06933043A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults.
Phase 1Help build intelligence for Navigator Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.